CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00006304
NCT00006304N/ACompleted

Pediatric Late Outcomes Protocol

National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Aug 31, 2001·Updated Oct 7, 2013

In Brief

An observational study for HIV Infections and HIV Seronegativity. Completed, across 92 sites in 2 countries.

Detailed Summary

As new drugs and vaccines are developed to prevent HIV disease progression and prolong survival of HIV infected patients, the short-term safety and effectiveness of these treatments are evaluated in research studies. However, the long-term effects, whether they are benefits or side effects, need to be studied as well. These long-term effects may have a greater impact on infants and children who are still growing and developing. The purpose of this study is to follow HIV-exposed and HIV infected infants, children, and adolescents who are seen at Pediatric AIDS Clinical Trials Group (PACTG) study sites. These patients will be observed for long-term benefits or any late harmful effects of medications or vaccines.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesPuerto Rico, United States

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 31, 2001
Study CompletionMay 1, 2002
TodayJul 2, 2026
Posted 24.8 years ago